Product
CMV-TCR-T cells
1 clinical trial
1 indication
Clinical trial
Adoptive Immunotherapy With Donor-derived CMV-TCR-T Cells for Patients With CMV Infection After Allogenic HSCTStatus: Recruiting, Estimated PCD: 2024-12-31
1 clinical trial
1 indication